据港交所文件：四川好医生云医疗科技集团股份有限公司向港交所提交上市申请书。

欧盟外交与安全政策高级代表卡拉斯：各方应继续秉持善意，为就关切领域达成可持续协议而努力。

TSMC’s near-term margin likely peaked in 1Q, according to Macquarie Group analysts. They expect 2Q revenue to grow sequentially, supported by strong AI demand and leadership in advanced nodes. However, 1Q margins may have been pressured by ramping 3nm capacity and initial 2nm mass production. External cost pressures are also likely to persist, including higher chemical prices amid geopolitical disruption. Gross margin is forecast to ease to around 62.4% in 2Q from an estimated 64% peak in 1Q, though the long-term growth outlook remains solid.